MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$6,728K
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
5,296
-
-
5,080
General and administrative
850
-
-
967
Total operating expenses
6,146
-
-
6,047
Loss from operations
-6,146
-6,274
-37,110*
-6,047
Interest income
885
914
1,244*
1,427
Interest expense
0
0
-88*
0
Other (loss) income
-9
1,036
1,589*
-85
Foreign exchange (loss) gain
-1,412
-1,132
513*
-1,201
Total other (loss) income
-536
818
3,257*
141
Loss before income taxes
-6,682
-5,456
-33,854*
-5,906
Income tax expense
46
49
40*
102
Net loss
-6,728
-5,505
-33,894
-6,008
Basic EPS
-0.22
-0.18
-1.112
-0.2
Diluted EPS
-
-
-1.112
-
Basic Average Shares
30,487,731
30,487,731
30,487,731
30,487,731
Diluted Average Shares
-
-
30,487,731
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$6,728K
(-283.14%↓ Y/Y)
Loss before income
taxes
-$6,682K
(-286.69%↓ Y/Y)
Income tax expense
$46K
(64.29%↑ Y/Y)
Loss from operations
-$6,146K
(3.00%↑ Y/Y)
Total other (loss)
income
-$536K
(-111.63%↓ Y/Y)
Interest income
$885K
(-42.16%↓ Y/Y)
Total operating
expenses
$6,146K
(-3.00%↓ Y/Y)
Foreign exchange (loss)
gain
-$1,412K
(-145.83%↓ Y/Y)
Other (loss) income
-$9K
(-200.00%↓ Y/Y)
Research and development
$5,296K
(-0.75%↓ Y/Y)
General and
administrative
$850K
(-15.00%↓ Y/Y)
Buy us a coffee
XBiotech Inc. (XBIT)
XBiotech Inc. (XBIT)